RBC Capital analyst Ben Hendrix lowered the firm’s price target on CVS Health (CVS) to $58 from $68 and keeps an Outperform rating on the ...

RBC Capital analyst Ben Hendrix maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $58.00.

Should Kennedy win Senate confirmation, his critics say he is threatening the achievements of a science-based public health ...

It was frustrating at times because there were a lot of serious significant [injuries]. ... But at the end of the day, I am ...

Shares of CVS Health Corp. CVS inched 0.44% higher to $54.27 Wednesday, on what proved to be an all-around favorable trading ...

Meta Platforms plans to introduce advertisements to its social media platform Threads next year, the Information reported on ...

CVS Health® (NYSE: CVS) today announced that Chief Financial Officer Tom Cowhey will participate in a fireside chat with investors at the Wolfe 2024 Healthcare Conference on November 19, 2024, at ...

"At bottom, the [integrated savings program] is an invitation to PBMs to engage in price fixing." The pharmacy benefit ...

CVS did not break out separate enrollment figures for fully insured group health plans when it posted its earnings.

More info RTÉ 2FM is set to announce a host of new faces at the station "early next year". The Irish Mirror can reveal 2FM ...

CVS Health on Wednesday named Steve Nelson, a former UnitedHealth insurance head, to run its Aetna business, where rising ...

This year has been defined by an unsuccessful fight against elevated medical costs for CVS. The third quarter was no ...